Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
Authors
Keywords
4CMenB, Effectiveness, Impact, Neisseria meningitis serogroup B, Vaccine, Safety
Journal
JOURNAL OF INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-30
DOI
10.1016/j.jinf.2021.04.031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience
- (2020) Catherine Isitt et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
- (2020) Shamez N. Ladhani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
- (2020) Helen S. Marshall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nephrotic syndrome in infants and toddlers before and after introduction of the meningococcal B vaccine programme in England: An ecological study
- (2020) Nick Andrews et al. VACCINE
- The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination
- (2020) Sydel R. Parikh et al. JOURNAL OF INFECTION
- Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidence
- (2020) Ray Borrow et al. JOURNAL OF INFECTION
- The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis
- (2020) J. Stowe et al. VACCINE
- Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia
- (2020) H.S. Marshall et al. VACCINE
- Targeted vaccination campaigns of teenagers after two clusters of B invasive meningococcal disease in Brittany, France, 2017
- (2020) Mathilde Pivette et al. BMC PUBLIC HEALTH
- First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England
- (2020) Shamez N Ladhani et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)
- (2020) Chiara Azzari et al. Vaccines
- Vaccines against Meningococcal Diseases
- (2020) Mariagrazia Pizza et al. Microorganisms
- Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program
- (2020) Shamez N Ladhani et al. CLINICAL INFECTIOUS DISEASES
- Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal
- (2020) Fernanda M. P. Rodrigues et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents
- (2020) Mark McMillan et al. CLINICAL INFECTIOUS DISEASES
- Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch
- (2019) G. Deceuninck et al. VACCINE
- Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
- (2019) Irene Rivero-Calle et al. Infection and Drug Resistance
- Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016
- (2018) Dirk Mentzer et al. Eurosurveillance
- Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination
- (2018) Alexandra Thabuis et al. Eurosurveillance
- Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada
- (2018) Gaston De Serres et al. VACCINE
- Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak—Oregon, 2015–2016
- (2017) Lucy A McNamara et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
- (2017) Helen Petousis-Harris et al. LANCET
- Adverse Events Following Vaccination with Bivalent rLP2086 (Trumenba®)
- (2017) Theresa M. Fiorito et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal
- (2017) Maria João Simões et al. PLoS One
- Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France
- (2017) Muhamed-Kheir Taha et al. VACCINE
- Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada
- (2017) Jean Longtin et al. Open Forum Infectious Diseases
- Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines
- (2016) Lorenzo Argante et al. BMC Medicine
- Routinely vaccinating adolescents against meningococcus: targeting transmission & disease
- (2016) Volker Vetter et al. Expert Review of Vaccines
- The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
- (2016) Ray Borrow et al. Expert Review of Vaccines
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
- (2016) Sydel R Parikh et al. LANCET
- Clinical experience with the meningococcal B vaccine, Bexsero ® : Prospects for reducing the burden of meningococcal serogroup B disease
- (2016) Philip S. Watson et al. VACCINE
- Notes from the Field:Outbreak of Serogroup B Meningococcal Disease at a University — California, 2016
- (2016) Hope H. Biswas et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
- (2015) L. A. McNamara et al. PEDIATRICS
- A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
- (2015) Stan L. Block et al. VACCINE
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- (2014) Robert C Read et al. LANCET
- Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
- (2013) M. D. Snape et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
- (2013) Julie A. Bettinger et al. VACCINE
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Advances in the Development of Vaccines againstNeisseria meningitidis
- (2010) Lionel K.K. Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now